Delivery Order SPE2DB24D1021-SPE2DB25FFBCB
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $2,564.77 delivery order by the Defense Logistics Agency on September 8, 2025, for the supply of Ambien CR 6.25 mg tablets (100 count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 9, 2025. The contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, valued at $1,804.72. This is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,360.04 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This competitive award utilizes firm fixed pricing and carries no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and a major distribution hub for...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,132.55 by the Defense Logistics Agency's Medical Supply Chain on September 23, 2025, for the delivery of Ambien CR 6.25 mg tablets in quantities of 100 units. The order, with a firm fixed price structure and an ultimate completion date of September 24, 2025, represents a non-competitive award under an existing contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,687.77 by the Defense Logistics Agency (DLA) on September 15, 2025, with an ultimate completion date of September 16, 2025. The contract is for the supply of Ambien CR 6.25 mg tablets in quantities of 100, to be delivered to the contractor's location in Conshohocken, Pennsylvania. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procurement on a non-set-aside basis. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ambien CR 6.25 mg tablets (100 count) on September 15, 2025, with a ceiling value of $3,974.14 and firm fixed pricing. This is a non-set-aside, competitively awarded contract with an ultimate completion date of September 16, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,610.42 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 14, 2025. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $3,606.82 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units. The contract employs firm fixed pricing and is not set aside, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This delivery order is issued under AmerisourceBergen's...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Ambien CR 6.25 mg tablets in a quantity of 100 units, valued at $2,148.62. This competitively awarded, non-set-aside delivery order carries a firm fixed price and is scheduled for completion by July 25, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at approximately $4,979 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg. This is a firm fixed-price, non-set-aside contract with a completion date of September 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. The delivery order represents a child contract under...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFBCBDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) on September 23, 2025, valued at $4,288.38 with an ultimate completion date of September 24, 2025. The contract is for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units. This award represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp supplies a broad portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support military and veteran healthcare systems. This specific delivery order for Ambien CR, a sedative-hypnotic medication, falls within the company's established role as a critical vendor for the DLA's global pharmaceutical support requirements. The award involved no set-aside designation and reflects AmerisourceBergen's continued capability to meet federal procurement standards through competitive processes and established contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 9/23/25 |